Final Grid

Saturday October 17, 2009

Sunday, October 18, 2009

Monday, October 19, 2009

Posters

Technician Program

PLEASE NOTE: There may have been some minor changes in the grid schedule since you accepted your assignment. Please contact Elaine Caplan at ercdvm@aol.com if you have an issue with your assignment. If you notice a correction that is needed on the grid itself (ie typographical errors, etc) please contact Sandi Strother at strothers@missouri.edu.
Saturday, October 17, 2009
Time	Title	Presenter
Resident Basic Science
9:15 AM	CHARACTERIZATION OF MICRORNA DYSREGULATION IN CANINE MAST CELL TUMORS	Dr. Joelle Fenger
9:25 AM	COMBINED IN VITRO EFFECTS OF CALCITRIOL WITH CCNU, VINBLASTINE, OR IMATINIB ON C2 CANINE MASTOCYTOMA CELLS	Dr. Erin Malone
9:35 AM	IN VITRO EFFECTS OF CANINE UMBILICAL CORD MATRIX STEM CELLS AND NANOPARTICLES ON CANINE OSTEOSARCOMA D17 CELL VIABILITY	Dr. Kimberly Reeds
9:45 AM	EVALUATION OF THE RECEPTOR TYROSINE KINASE INHIBITOR, MASITINIB MESYLATE, IN FELINE VACCINE ASSOCIATED SARCOMA CELL LINES AND HEALTHY CATS	Dr. Meighan Daly
10:30 AM	DETERMINATION OF ROSIGLITAZONE IN PLASMA OF CANCER BEARING DOGS	Dr. Sara Frazier
10:40 AM	PRELIMINARY RESULTS OF GENE EXPRESSION ANALYSIS OF METASTATIC AND NON-METASTATIC CANINE SOFT TISSUE SARCOMAS	Dr. Jennifer Mahoney
10:50 AM	5-LIPOXYGENASE EXPRESSION IN HYPERPLASTIC, INFLAMED, AND NEOPLASTIC CANINE PROSTATE TISSUES	Dr. Laura Goodman Accola
Resident Clinical Science
11:00 AM	DETECTION OF TUMOR NECROSIS FACTOR ALPHA (TNF-ALPHA) IN DOGS WITH LYMPHOMA	Dr. Jennifer Hofer
11:10 AM	INCREASED MONOCYTE CHEMOTACTIC PROTEIN-1 CONCENTRATIONS ARE ASSOCIATED WITH DECREASED DISEASE-FREE INTERVAL AND SURVIVAL TIME IN DOGS WITH LYMPHOMA	Dr. Jim Perry
11:20 AM	COMPARISON OF SOMATOSTATIN ANALOGUES AND CONVENTIONAL IMAGING MODALITIES FOR STAGING OF CANINE B-CELL LYMPHOMA.	Dr. Kimberly Ringen
11:30 AM	CLINICAL AND HISTOPATHOLOGICAL CHARACTERIZATION OF CANINE INDOLENT LYMPHOMA	Dr. Kendra Flood
11:40 AM	USE OF RADIATION THERAPY IN THE MANAGEMENT OF ORAL LYMPHOMA IN DOGS: 16 CASES.	Mr. Davide Berlato
11:50 AM	DOXORUBICIN AND CYCLOPHOSPHAMIDE FOR THE TREATMENT OF CANINE LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED STUDY	Dr. Janet Lori
1:40 PM	ADDITION OF DTIC TO A CHOP-BASED PROTOCOL FOR CANINE T CELL LYMPHOMA	Dr. Carol DeRegis
1:50 PM	EVALUATION OF ADVERSE EVENTS IN CATS RECEIVING LONG-TERM PIROXICAM	Dr. Julie Bulman-Fleming
2:00 PM	HEMATOLOGIC CHANGES IN REPEATEDLY ANESTHETIZED, TUMOR-BEARING DOGS UNDERGOING DEFINITIVE RADIATION THERAPY.	Dr. Todd Erfourth
2:10 PM	SUCCESSFULLY MANAGED VINCRISTINE OVERDOSE	Dr. Takashi Higuchi
2:20 PM	EFFICACY OF CERENIA(TM) IN THE PREVENTION OF DELAYED VOMITING ASSOCIATED WITH DOXORUBICIN ADMINISTRATION	Dr. Suzanne Rau
2:30 PM	HYDROPULSION TO BIOPSY AND DEBULK NASAL TUMORS	Dr. Elizabeth Ashbaugh
2:40 PM	COX-2 EXPRESSION AND ITS CORRELATION WITH SURVIVAL IN CANINE NASAL CARCINOMAS	Ms. Zoe Belshaw
2:50 PM	REIRRADIATION OF CANINE NASAL TUMORS: A CASE SERIES FROM 1998-2008	Dr. David Bommarito
3:20 PM	CYTOLOGIC ACCURACY IN DIAGNOSING NEOPLASIA FROM 68 CANINE ORAL MASSES	Dr. Sandra Barnard
3:30 PM	QUANTITATION OF PROSTATE SPECIFIC MEMBRANE ANTIGEN IN CANINE HEMANGIOSARCOMA CELL LINES	Dr. Jen Coyle
3:40 PM	ESVONC JUNIOR RESEARCH AWARD REDUCED PTEN PROTEIN EXPRESSION AND ITS PROGNOSTIC IMPLICATIONS IN CANINE AND FELINE MAMMARY TUMOURS	Dr. Lorenzo Ressel
3:50 PM	COMPARISON OF CYTOLOGY, FLOW CYTOMETRY USING CD18, AND HISTOPATHOLOGY WITH IMMUNOHISTOCHEMISTRY (CD18) FOR THE DIAGNOSIS OF CANINE HISTIOCYTIC SARCOMA.	Dr. Jennifer Wiley
4:00 PM	A RETROSPECTIVE ANALYSIS OF 19 CASES OF PERIARTICULAR HISTIOCYTIC SARCOMA IN DOGS: 2004-2008	Dr. Shawna Klahn
4:10 PM	OPTIMIZING METRONOMIC CHEMOTHERAPY USING TUMOR BIOMARKERS IN DOGS WITH SOFT TISSUE SARCOMA	Dr. Jenna Burton
4:20 PM	ULTRASOUND MEASUREMENT OF ADRENAL SIZE IN DOGS WITH ATYPICAL CUSHINGS	Dr. Chelsea Tripp
4:30 PM	A COMPARISON OF CD4+CD25+FOXP3+ T REGULATORY CELLS IN BLOOD AND LYMPH NODES OF CANINE OSTEOSARCOMA PATIENTS AND HEALTHY CONTROLS	Dr. Kerry Rissetto